z-logo
open-access-imgOpen Access
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial
Author(s) -
M.S. Cohen,
Ajay Nirula,
Mark J. Mulligan,
Richard Novák,
Mary Marovich,
Catherine Yen,
Alexander Stemer,
Stockton Mayer,
David A. Wohl,
Blair Brengle,
Brian T. Montague,
Ian Frank,
Russell J. McCulloh,
Carl J. Fichtenbaum,
Brad Lipson,
Nashwa Gabra,
Julio A. Ramírez,
Christine Thai,
Wairimu Chege,
Margarita M. Gomez Lorenzo,
Nirupama Sista,
Jennifer Farrior,
Meredith E. Clement,
Elizabeth R. Brown,
Kenneth L. Custer,
Jacob Van Naarden,
Andrew C. Adams,
Andrew E. Schade,
Matan C. Dabora,
Jack Knorr,
Karen Price,
Janelle Sabo,
Jay Tuttle,
Paul Klekotka,
Lei Shen,
Daniel Skovronsky,
BLAZE- Investigators
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/cew2-rc27
Subject(s) - covid-19 , skilled nursing facility , placebo , medicine , incidence (geometry) , nursing , randomized controlled trial , nursing staff , placebo group , clinical trial , gerontology , alternative medicine , virology , outbreak , physics , disease , pathology , infectious disease (medical specialty) , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom